T

Tongling Jieya Biologic Technology Co Ltd
SZSE:301108

Watchlist Manager
Tongling Jieya Biologic Technology Co Ltd
SZSE:301108
Watchlist
Price: 26.4 CNY 2.92% Market Closed
Market Cap: 2.1B CNY
Section:
Relative Value
Relative Value
Valuation Multiples
Multiples Across Competitors
See Also

Relative Value

The Relative Value of one Tongling Jieya Biologic Technology Co Ltd stock under the Base Case scenario is 12.07 CNY. Compared to the current market price of 26.4 CNY, Tongling Jieya Biologic Technology Co Ltd is Overvalued by 54%.

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

Relative Value
Base Case
12.07 CNY
Overvaluation 54%
Relative Value
Price
T
Worst Case
Base Case
Best Case

Valuation Multiples

3.7
P/S
P/S
Price to Sales
3.7
vs History
78
vs Industry
12
Median 3Y
4
Median 5Y
4
Industry
1
Forward
2.9
More Details
38.1
P/E
P/E
Price to Earnings
38.1
vs History
12
vs Industry
13
Median 3Y
24
Median 5Y
23.7
Industry
16.9
Forward
15.9
More Details
27.3
P/OCF
P/OCF
Price to OCF
27.3
vs History
19
vs Industry
14
Median 3Y
16.4
Median 5Y
16.4
Industry
11.8
More Details
Negative
P/FCFE
P/FCFE
Price to FCFE
N/A
vs History
vs Industry
12
Median 3Y
10.9
Median 5Y
10.9
Industry
17.1
More Details
1.2
P/B
P/B
Price to Book Value
1.2
vs History
85
vs Industry
51
Median 3Y
1.5
Median 5Y
1.5
Industry
1.5
More Details
2
EV/S
EV/S
Enterprise Value to Sales
2
vs History
78
vs Industry
26
Median 3Y
2.2
Median 5Y
2.2
Industry
1.1
Forward
1.6
More Details
10.1
EV/GP
EV/GP
Enterprise Value to Gross Profit
10.1
vs History
39
vs Industry
15
Median 3Y
8.8
Median 5Y
8.8
Industry
3.7
More Details
35.1
EV/EBITDA
EV/EBITDA
Enterprise Value to EBITDA
35.1
vs History
12
vs Industry
9
Median 3Y
13
Median 5Y
13
Industry
9.8
Forward
6
More Details
35.1
EV/EBIT
EV/EBIT
Enterprise Value to EBIT
35.1
vs History
12
vs Industry
11
Median 3Y
13
Median 5Y
13
Industry
12.7
Forward
7.4
More Details
15.1
EV/OCF
EV/OCF
Enterprise Value to OCF
15.1
vs History
31
vs Industry
28
Median 3Y
9.2
Median 5Y
9.2
Industry
12.2
More Details
Negative
EV/FCFF
EV/FCFF
Enterprise Value to FCFF
N/A
vs History
vs Industry
16
Median 3Y
5.6
Median 5Y
5.6
Industry
15.2
More Details
1.2
EV/IC
EV/IC
Enterprise Value to IC
1.2
vs History
85
vs Industry
39
Median 3Y
2.2
Median 5Y
2.2
Industry
1.2
More Details

Multiples Across Competitors

Competitors Multiples
Tongling Jieya Biologic Technology Co Ltd Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
Market Cap P/S P/E EV/EBITDA EV/EBIT
CN
Tongling Jieya Biologic Technology Co Ltd
SZSE:301108
2.1B CNY 3.7 38.1 35.1 35.1
FR
L'Oreal SA
PAR:OR
188.8B EUR 4.3 29.5 19.1 23.4
UK
Unilever PLC
LSE:ULVR
115.3B GBP 2.3 24 146.7 169.7
IN
Hindustan Unilever Ltd
NSE:HINDUNILVR
5.2T INR 8.4 48.9 34.7 38.1
UK
HALEON PLC
LSE:HLN
35.5B GBP 3.2 24.6 14.6 16.5
DE
Beiersdorf AG
XETRA:BEI
26.5B EUR 2.7 29.1 12.3 15
US
Estee Lauder Companies Inc
NYSE:EL
24.3B USD 1.6 -34.6 12.5 19.5
MY
Nova Wellness Group Bhd
KLSE:NOVAMSC
93.4B MYR 2 551.3 -15 367.6 -32 205.7 -32 205.7
JP
Kao Corp
TSE:4452
3.1T JPY 1.9 28.4 12.2 19.6
IN
Godrej Consumer Products Ltd
NSE:GODREJCP
1.2T INR 8.3 -258.2 38 40.8
IN
Dabur India Ltd
NSE:DABUR
884.6B INR 7.1 49.2 36.9 45
P/E Multiple
Earnings Growth PEG
CN
T
Tongling Jieya Biologic Technology Co Ltd
SZSE:301108
Average P/E: 34
38.1
N/A N/A
FR
L'Oreal SA
PAR:OR
29.5
10%
2.9
UK
Unilever PLC
LSE:ULVR
24
15%
1.6
IN
Hindustan Unilever Ltd
NSE:HINDUNILVR
48.9
8%
6.1
UK
HALEON PLC
LSE:HLN
24.6
13%
1.9
DE
Beiersdorf AG
XETRA:BEI
29.1
13%
2.2
US
Estee Lauder Companies Inc
NYSE:EL
Negative Multiple: -34.6
45%
N/A
MY
N
Nova Wellness Group Bhd
KLSE:NOVAMSC
Negative Multiple: -15 367.6 N/A N/A
JP
Kao Corp
TSE:4452
28.4
10%
2.8
IN
Godrej Consumer Products Ltd
NSE:GODREJCP
Negative Multiple: -258.2 N/A N/A
IN
Dabur India Ltd
NSE:DABUR
49.2
9%
5.5
EV/EBITDA Multiple
EBITDA Growth EV/EBITDA to Growth
CN
T
Tongling Jieya Biologic Technology Co Ltd
SZSE:301108
Average EV/EBITDA: 36.2
35.1
N/A N/A
FR
L'Oreal SA
PAR:OR
19.1
8%
2.4
UK
Unilever PLC
LSE:ULVR
146.7
5%
29.3
IN
Hindustan Unilever Ltd
NSE:HINDUNILVR
34.7
7%
5
UK
HALEON PLC
LSE:HLN
14.6
5%
2.9
DE
Beiersdorf AG
XETRA:BEI
12.3
3%
4.1
US
Estee Lauder Companies Inc
NYSE:EL
12.5
4%
3.1
MY
N
Nova Wellness Group Bhd
KLSE:NOVAMSC
Negative Multiple: -32 205.7
142%
N/A
JP
Kao Corp
TSE:4452
12.2
7%
1.7
IN
Godrej Consumer Products Ltd
NSE:GODREJCP
38
9%
4.2
IN
Dabur India Ltd
NSE:DABUR
36.9
9%
4.1

See Also

Summary
Intrinsic value, competitors valuation, and company profile.
DCF Valuation
Stock valuation using Discount Cash Flow valuation method.
Relative Valuation
Stock valuation using valuation multiples.
Wall Street Estimates
Price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
Stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
Back to Top
ALPHA SPREAD
Follow us
Join more than 243,000+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks Wide Economic Moat Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2025 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.